Article thumbnail

Renal Function but Not Asymmetric Dimethylarginine Is Independently Associated with Retinopathy in Type 2 Diabetes

By Katarzyna Krzyzanowska, Friedrich Mittermayer, Gerit H. Schernthaner, Simon Brunner, Johanna M. Brix, Stefan Aschauer, Florian Höllerl, Michael Wolzt and Guntram Schernthaner

Abstract

Background. Asymmetric dimethylarginine (ADMA) is associated with macrovascular disease and possibly with microangiopathy in type 2 diabetes (T2DM). We tested the hypothesis that ADMA is related to diabetic retinopathy (DR) independently of macrovascular disease. Methods. This cross-sectional study included 127 T2DM patients selected to achieve equal distributions of patients with and without macrovascular disease in the groups with and without DR. Results. Patients with DR had increased ADMA, longer diabetes duration, and reduced glomerular filtration rate (GFR). ADMA correlated with GFR (ρ = -0.35; P < .001), diabetes duration (ρ = 0.19; P = .048), and age (ρ = 0.19; P = .033). Logistic regression analysis revealed an association of ADMA with DR. After adjustment for macrovascular disease, this association remained significant (OR 1.48; 95% CI: 1.02–2.15; P = .039). Inclusion of GFR and T2DM duration into the model abolished this significant relationship. GFR remained the only independent predictor for DR. A 10 mL/min/1.73 m2 GFR decrease was associated with DR in a multivariate model (OR 1.30; 95% CI: 1.08–1.56; P = .006). Conclusions. These findings indicate an association between ADMA and DR in T2DM independent of macrovascular disease. This relationship is modified by GFR, the only parameter significantly related to DR in multivariate analysis

Topics: Clinical Study
Publisher: SAGE-Hindawi Access to Research
OAI identifier: oai:pubmedcentral.nih.gov:3099195
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation.ModificationofDiet
  2. (2004). a r n o w ,P .H o v i n d ,T .T e e r l i n k ,C .D .A .S t e h o u w e r ,a n d
  3. (2004). Acute Escherichia coli endotoxaemia decreases the plasmaL-arginine/asymmetrical dimethylarginine ratio in humans,”Clinical
  4. (2005). Associations between retinal microvascular abnormalities and declining renal function in the elderly population:
  5. (2007). Asymmetric dimethylarginine (ADMA) in the aqueous humor of diabetic patients,”
  6. (2009). Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy
  7. (2007). Asymmetric dimethylarginine predicts cardiovascular events
  8. (2007). Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with type 2 diabetes and albuminuria,”
  9. (2002). B¨ o g e r ,S .M .B o d e - B ¨ oger et al., “Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease,”
  10. (1998). D a v i s ,M .R .F i s h e r ,R .E .G a n g n o ne ta l . ,“ R i s kf a c t o r s for high-risk proliferative diabetic retinopathy and severe visualloss:earlyTreatmentDiabeticRetinopathyStudyReport
  11. (2002). Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma6 Cardiology Research and Practice and other biological samples by high-performance liquid chromatography,”
  12. (2005). Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study,” Diabetes Care,
  13. (1994). Dyslipidaemia and cardiovascular disease in non-insulin-dependent diabetic patients with and without diabetic nephropathy,”
  14. (1991). Early treatment diabeticretinopathy study design and baseline patient characteristics.
  15. (1991). Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic
  16. (1991). Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10.
  17. (2007). h e u n g ,J .J .W a n g ,R .K l e i n ,D .J .C o u p e r ,A .R .S h a r r e t t , andT.Y.Wong,“Diabetic retinopathyandtheriskofcoronary heartdisease:theAtherosclerosisRiskin CommunitiesStudy,” Diabetes Care,
  18. (2007). M a l e c k i ,A .U n d a s ,K .C y g a n e ke ta l . ,“ P l a s m aa s y m m e t -ric dimethylarginine (ADMA) is associated with retinopathy
  19. (1989). N e l s o n ,J .A .W o l f e ,M .B .H o r t o n ,D .J .P e t t i t t ,P . H .B e n n e t t ,a n dW .C .K n o w l e r ,“ P r o l i f e r a t i v er e t i n o p a t h y in NIDDM. Incidence and risk factors in Pima Indians,” Diabetes,
  20. (2008). Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium
  21. (2004). W o n g ,J .C o r e s h ,R .K l e i ne ta l . ,“ R e t i n a lm i c r o v a s c u l a r abnormalities and renal dysfunction: the atherosclerosis risk in communities study,”
  22. (1988). W.F.Wilson,“Diabetic retinopathyandcardiovasculardisease in type II diabetics. The framingham heart study and the framinghameye study,”